These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34907712)

  • 1. Synergism between WLBU2 peptide and antibiotics against methicillin-resistant Staphylococcus aureus and extended-spectrum beta-lactamase-producing Enterobacter cloacae.
    Elsalem L; Al Sheboul S; Khasawneh A
    J Appl Biomed; 2021 Mar; 19(1):14-25. PubMed ID: 34907712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
    Geitani R; Ayoub Moubareck C; Touqui L; Karam Sarkis D
    BMC Microbiol; 2019 Mar; 19(1):54. PubMed ID: 30849936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of colistin is resurrected by Stephania suberosa Forman extract against colistin-resistant Enterobacter cloacae.
    Suknasang S; Teethaisong Y; Kabkhunthod S; Mingsiritom N; Chueakwon P; Eumkeb G
    Lett Appl Microbiol; 2019 Aug; 69(2):128-135. PubMed ID: 31148182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synergistic antimicrobial effect of imipenem and colistin against an isolate of multidrug-resistant Enterobacter cloacae.
    Lin KH; Chuang YC; Lee SH; Yu WL
    J Microbiol Immunol Infect; 2010 Aug; 43(4):317-22. PubMed ID: 20688292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic additive and synergistic action of rutin, morin and quercetin against methicillin resistant Staphylococcus aureus.
    Amin MU; Khurram M; Khattak B; Khan J
    BMC Complement Altern Med; 2015 Mar; 15():59. PubMed ID: 25879586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
    Jean SS; Ko WC; Hsueh PR;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106016. PubMed ID: 32422316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hope for ineffective antibiotics to return to treatment: investigating the anti-biofilm potential of melittin alone and in combination with penicillin and oxacillin against multidrug resistant-MRSA and -VRSA.
    Jalalifar S; Razavi S; Mirzaei R; Irajian G; Pooshang Bagheri K
    Front Microbiol; 2023; 14():1269392. PubMed ID: 38370578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity and mechanism of action of ceftazidime and apigenin combination against ceftazidime-resistant Enterobacter cloacae.
    Eumkeb G; Chukrathok S
    Phytomedicine; 2013 Feb; 20(3-4):262-9. PubMed ID: 23218402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WLBU2 Antimicrobial Peptide as a Potential Therapeutic for Treatment of Resistant Bacterial.
    Elsalem L; Khasawneh A; Al Sheboul S
    Turk J Pharm Sci; 2022 Feb; 19(1):110-116. PubMed ID: 35227034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
    Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC
    Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
    Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New erythromycin derivatives enhance β-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Li Z; He M; Dong X; Lin H; Ge H; Shen S; Li J; Ye RD; Chen D
    Lett Appl Microbiol; 2015 Apr; 60(4):352-8. PubMed ID: 25588530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).
    Rishi P; Vij S; Maurya IK; Kaur UJ; Bharati S; Tewari R
    Microb Pathog; 2018 Nov; 124():11-20. PubMed ID: 30118800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms.
    Dosler S; Mataraci E
    Peptides; 2013 Nov; 49():53-8. PubMed ID: 23988790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms.
    Mataraci E; Dosler S
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6366-71. PubMed ID: 23070152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of the Antibiotic Susceptibility of Methicillin-Resistant
    Wang M; Ma B; Ni Y; Xue X; Li M; Meng J; Luo X; Fang C; Hou Z
    Microb Drug Resist; 2021 Mar; 27(3):337-341. PubMed ID: 32721267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY; Zhang XJ; Han J; Li YQ; Wang GC
    BMC Complement Altern Med; 2015 Dec; 15():425. PubMed ID: 26627468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility].
    She D; Liu Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.